Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Finasteride is effective for hair loss but has controversial side effects.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Provenge extends prostate cancer survival by about 4 months.

The compound was successfully made and shows potential for treating prostate cancer.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

The document aimed to understand how certain treatments affect blood vessel growth in rat prostates.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Finasteride may reduce prostate cancer risk.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Long-term diabetes is linked to lower prostate cancer risk.